Day: October 8, 2024

SINGAPORE, Oct. 08, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI powered education and acceleration group, today confirmed the purchase by Roger Hamilton, its CEO, of 500,000 ordinary shares from the Company. The purchase of the ordinary shares was approved by the Board on August 9, 2024 at a per share price equal to 105% of the closing price on the prior trading day to the date of purchase, in a combination of cash and conversion of debt due from the Company. Based upon the closing price on the prior trading day prior to the date Roger Hamilton provided notice of intent to purchase, which was September 24, 2024 (which was $0.866), Mr. Hamilton is acquiring the shares today at a purchase price of $0.91 per share. The most recent application to the company follows...

TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is proud to announce that it has been contracted as a supplier of MDMA to a proposed clinical trial at the University of Texas, San Antonio. Pursuant to a submitted grant funding application by the principals, the contract envisions the creation of a new dosage form for LaNeo™ MDMA, which will subsequently be tested in an investigator-initiated human clinical trial. “PharmAla stands ready to support researchers not only with our existing API and 40mg capsules, but in the development of new and novel dosage forms for LaNeo™ MDMA,” said...

Panevėžys Regional Court has approved the restructuring of SBA Group company Utenos Trikotažas, which aims to shift toward profitability and ensure sustainable continuity. The court has also approved the company’s four-year restructuring plan, which outlines the necessary measures and funding sources for its transformation. “We have been anticipating this court decision, as we have already initiated important processes and negotiations that are crucial for the company’s successful transformation. The restructuring will give us time to reorganize our business model and ensure the company’s solvency as well as the long-term fulfillment of its obligations,” says Dovilė Tamoševičienė, Chair of the Management Board of Utenos Trikotažas. The restructuring plan approved by the Court focuses on further efficiency improvements...

Please click to view image Vancouver, BC, Oct. 08, 2024 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (CSE: SPIR) (“Spirit” or the “Purchaser”), a focused blockchain technology and digital asset management company, is pleased to announce the acquisition of Dogecoin Portfolio Holdings Corp. (“Dogecoin Holdings”), a company founded by a team of visionary entrepreneurs and supporters of Dogecoin (DOGE), one of the largest cryptocurrencies by market capitalization. Launched in 2013, Dogecoin has grown from a pioneering “memecoin” to a highly decentralized and liquid cryptocurrency, supported by over 6.7 million active addresses and a vibrant community of 2.5 million members on the r/dogecoin subreddit. This acquisition represents a pivotal milestone in Spirit’s strategic growth plan,...

Leading Battery Analytics Software Provider and Battery Materials and Technology Innovator Join Forces to Optimize Global Battery Development and Production HALIFAX, Nova Scotia, Oct. 08, 2024 (GLOBE NEWSWIRE) — Voltaiq, the industry leader in battery quality analytics software, and NOVONIX Limited (NASDAQ: NVX, ASX: NVX), a leading battery materials and technology company, today announced a strategic partnership aimed at revolutionizing the battery industry’s approach to quality control and efficiency. This collaboration comes at a time when battery companies are under pressure to optimize operations in an increasingly competitive global market. The partnership between Voltaiq and NOVONIX represents a significant step forward in addressing these challenges, combining Voltaiq’s best-in-class battery quality analytics...

SARASOTA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) — Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related health conditions, has completed a key study for their new concussion drug, ONP-002. This drug is designed to be delivered through the nose, which could help it reach the brain quickly after a head injury. The recent study shows that the drug successfully targets areas inside the nose that are connected to the brain. This makes it more likely to reach and treat the brain after a concussion. Intranasal casting studies are valued by the FDA for pharmaceuticals delivered via the nasal passage and accept such studies in FDA submissions. Oragenics is now preparing to move forward with human testing (Phase II) in patients who come to the emergency room with a concussion, aiming to give...

PHILADELPHIA, Oct. 08, 2024 (GLOBE NEWSWIRE) — Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its third-quarter 2024 financial results at 6 a.m. ET on Wednesday, October 30. The release and supporting materials will be posted to Axalta’s Investor Relations site. In addition, the company will host a conference call at 8 a.m. ET on October 30. Chris Villavarayan, Chief Executive Officer and President, and Carl Anderson, Senior Vice President and Chief Financial Officer, will review the company’s financial performance for the period. A live webcast of the conference call will be available here. A replay of the webcast will be posted shortly after the call and will remain accessible through October 30, 2025. The dial-in phone number for the conference call is 1-800-267-6316 and the conference...